Q1 2014

Source filing unavailable

Q1 2014 · —

Revenue

$28.00K

no prior Q1 2013 on file

Net Income

-$75.74M

N/M vs Q1 2013

EPS Diluted

-$3.25

N/M vs Q1 2013

Operating Income-$22,062,000N/M

Operating Cash Flow-$9,805,673N/M

Free Cash Flowderived

Same quarter

Metric	Q1 2014	Q1 2013	Q1 2012	Q1 2011
Revenue	$28.00K	—	$0.00	$0.00
Net Income	-$75.74M	-$4.87M	-$3.51K	-$3.52K
EPS Diluted	-$3.25	-$0.46	—	—

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Travere Therapeutics, Inc. · CIK 1438533 · Engraved from SEC EDGAR